Sean Moloughney, Editor02.16.21
A proprietary extract of Alpinia galanga (a plant in the ginger family), known as enXtra has been granted a U.S. patent for improved cognitive performance.
This method of use patent covers a formulation of Alpinia galanga for improvement of cognitive performance such as mental alertness and increased attention that has previously been demonstrated in five clinical studies.
enXtra is a registered trademark of EnoVate Biolife, Private Limited. OmniActive Health Technologies is the official marketing partner for enXtra in North America.
"While caffeine continues to lead in the nootropic space because of its experiential benefits, consumers are still constantly looking for alternatives, said Kimberly Smith, chief marketing officer at OmniActive Health Technologies. “Clinically backed enXtra provides a novel, natural caffeine alternative for increased alertness and sustained attention and focus. We are thrilled that this patent will allow our customers to promote these cognitive health claims for Alpinia galanga."
enXtra was also recently certified by Informed Ingredient, a quality assurance certification for dietary supplement manufacturing facilities, which ensures that ingredients have been tested for banned substances and comply with WADA (World Anti-Doping Agency) guidelines. The certification also confirms that ingredients are manufactured to high quality standards.
"The patent and the Informed Ingredient certification are important steps in further building enXtra's unique position in the market," said Amol Pathak, director of business & strategy at Enovate Biolife.
This method of use patent covers a formulation of Alpinia galanga for improvement of cognitive performance such as mental alertness and increased attention that has previously been demonstrated in five clinical studies.
enXtra is a registered trademark of EnoVate Biolife, Private Limited. OmniActive Health Technologies is the official marketing partner for enXtra in North America.
"While caffeine continues to lead in the nootropic space because of its experiential benefits, consumers are still constantly looking for alternatives, said Kimberly Smith, chief marketing officer at OmniActive Health Technologies. “Clinically backed enXtra provides a novel, natural caffeine alternative for increased alertness and sustained attention and focus. We are thrilled that this patent will allow our customers to promote these cognitive health claims for Alpinia galanga."
enXtra was also recently certified by Informed Ingredient, a quality assurance certification for dietary supplement manufacturing facilities, which ensures that ingredients have been tested for banned substances and comply with WADA (World Anti-Doping Agency) guidelines. The certification also confirms that ingredients are manufactured to high quality standards.
"The patent and the Informed Ingredient certification are important steps in further building enXtra's unique position in the market," said Amol Pathak, director of business & strategy at Enovate Biolife.
